Dr. Dobos received her Ph.D. from Colorado State University, applying proteomics mass spectrometry to describe novel glycosylation of proteins from Mycobacterium tuberculosis. She continued her research at the Centers for Disease Control and Prevention, working on infection models of Mycobacterium spp., prior to taking an appointment at the Mayo Clinic Research Center where she gained experience in NIAID contracts managing the day-to-day activities of an eosinophil research and animal modeling contract. She returned to CSU in 2002 to facilitate a NIAID tuberculosis contract where she subsequently served as PI from 2007-2011. In 2014, Dr. Dobos accepted the appointment as Associate Director of the Office of Research Integrity and Compliance Review, which manages the operations of all bioethics compliance committees for the university as well other required research compliance activities, and regulated research. She subsequently became the director of this office in January of 2016.
Ph.D., Colorado State University